English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52805625    ???header.onlineuser??? :  571
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yi heng"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-50 of 50  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2024-12-17 Long-Term Statin Use Is Associated With Reduced Rates of Adverse Events in Patients With Newly Diagnosed Atrial Fibrillation Huang;Ting-Chun;Yap;Li-Hao;Chen;Chao-Yu;Lin;Hui-Wen;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2024-08-2 Clinical outcome in hypertensive patients treated with amlodipine plus bisoprolol or plus valsartan Li;Yi-Heng;Lin;Hui-Wen;Gottwald-Hostalek;Ulrike;Lin;Hung-Wei;Lin;Sheng-Hsiang
國立成功大學 2024-08 The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions Goh;Jen, Rachel Sze;Chong;Bryan;Jayabaskaran;Jayanth;Jauhari;Metta, Silingga;Chan;Pang, Siew;Kueh;Wah, Martin Tze;Shankar;Kannan;Li;Henry;Chin;Han, Yip;Kong;Gwyneth;Anand;Vijay, Vickram;Chan;Andrew, Keith;Sukmawati;Indah;Toh;Anne, Sue;Muthiah;Mark;Wang;Jiong-Wei;Tse;Gary;Mehta;Anurag;Fong;Alan;Baskaran;Lohendran;Zhong;Liang;Yap;Jonathan;Yeo;Keong, Khung;Hausenloy;Derek, J.;Tan;Chieh, Jack Wei;Chao;Tze-Fan;Li;Yi-Heng;Lim;Lynn, Shir;Chan;Hui, Koo;Loh;Huan, Poay;Chai;Ping;Yeo;Cheng, Tiong;Low;Adrian, F.;Lee;Hang, Chi;Foo;Roger;Tan;Cheem, Huay;Yip;James;Rao;Sarita;Honda;Satoshi;Yasuda;Satoshi;Kajiya;Takashi;Goto;Shinya;Yan;Bryan, P.;Zhou;Xin;Figtree;Gemma, A.;Mamas;Mamas, A.;Kim;Yongcheol;Jeong;Young-Hoon;Kim;Hyun, Moo;Park;Duk-Woo;Park;Seung-Jung;Richards;Mark, A.;Chan;Mark, Y.;Lip;Gregory, Y. H.;Chew;Nicholas, W. S.
國立成功大學 2024-06 A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study Hsiao;Yu-Chung;Lee;Thung-Lip;Lin;Fang-Ju;Hsuan;Chin-Feng;Yeh;Chih-Fan;Chang;Wei-Tien;Kao;Hsien-Li;Jeng;Jiann-Shing;Wu;Yen-Wen;Hsieh;I-Chang;Fang;Ching-Chang;Wang;Kuo-Yang;Chang;Kuan-Cheng;Lin;Tsung-Hsien;Sheu;Wayne, Huey-Herng;Li;Yi-Heng;Yin;Wei-Hsian;Yeh;Hung-;I;Chen;Jaw-Wen;Wu;Chau-Chung
國立成功大學 2024-06 Risk of Hemorrhagic Stroke among Patients Treated with High-Intensity Statins versus Pitavastatin-Ezetimibe: A Population Based Study Chen;Po-Sheng;Lin;Jia-Ling;Lin;Hui-Wen;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2024-03 2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction Li;Yi-Heng;Wang;Chun-Chieh;Hung;Chung-Lieh;Wu;-Wen, Yen;Hsu;Chih-Hsin;Tsou;Yi-Liang;Wang;-Hung, Chao;Wu;-Kai, Cho;Lin;-Lin, Po;Chang;-Yu, Hung;Sung;Shih-Hsien;Chen;Zheng-Wei;Juang;Jimmy, Jyh-Ming;Wang;Tzung-Dau;Chen;Wen-Jone
國立成功大學 2024-03 Socioeconomic Disparity in the Effect of SARS-CoV-2 on Outpatient Visits among People with Type 2 Diabetes in Taiwan Liu;Kuan-Hung;Kuo;Teng-Lung;Ko;Nai-Ying;Li;Yi-Heng;Ko;Wen-Chien;Martini;Santi;Li;Chung-Yi
國立成功大學 2024-02 Statin Use Is Associated With Reduced Heart Failure and Risk of Death in Non-Hodgkin Lymphoma Chen;-Yu, Chao;Chang;-Ting, Wei;Lin;-Wen, Hui;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2024-01 Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases Cheng;Pin-Nan;Chen;Wen-Jone;Hou;Charles, Jia-Yin;Lin;Chih-Lin;Chang;Ming-Ling;Wang;Chia-Chi;Chang;Wei-Ting;Wang;Chao-Yung;Lin;Chun-Yen;Hung;Chung-Lieh;Peng;Cheng-Yuan;Yu;Ming-Lung;Chao;Ting-Hsing;Huang;Jee-Fu;Huang;Yi-Hsiang;Chen;Chi-Yi;Chiang;Chern-En;Lin;Han-Chieh;Li;Yi-Heng;Lin;Tsung-Hsie;Kao;Jia-Horng;Wang;Tzung-Dau;Liu;Ping-Yen;Wu;Yen-Wen;Liu;Chun-Jen
國立成功大學 2023-07-19 Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients Hsu;Yu-Ling;Huang;Mu-Shiang;Chang;Hsien-Yuan;Lee;Cheng-Han;Chen;Dao-Peng;Li;Yi-Heng;Chao;Ting-Hsin;Liu;Yen-Wen;Liu;Ping-Yen
國立成功大學 2023-05 Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non-Small Cell Lung Cancer in Taiwan Chang;Wei-Ting;Lin;Hui-Wen;Chang;Ting-Chia;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2023-04-28 Impact of infection-related admission in patients with heart failure: a 10 years national cohort study Chen;Chao-Yu;Lee;Cheng-Han;Lin;Hui-Wen;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2023-04-17 The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan Chang;Wei-Ting;Lin;Hui-Wen;Chang;Ting-Chia;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2023-04 Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia Chang;Wei-Ting;Lin;Hui-Wen;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2022-12-15 Soluble tumor endothelial marker 1 in heart failure with reduced ejection fraction: A pilot study Feng;Wen-Han;Chen;Po-Sheng;Chung;Hsing-Chun;Lin;Yi-Hsiung;Li;Yi-Heng
國立成功大學 2022-12 Effects of Cilostazol on Angiogenesis in Diabetes through Adiponectin/Adiponectin Receptors/Sirtuin1 Signaling Pathway Tseng;Shih-Ya;Chang;Hsien-Yuan;Li;Yi-Heng;Chao;Ting-Hsing
國立成功大學 2022-12 2022 Taiwan lipid guidelines for primary prevention Huang;Po-Hsun;Lu;Ya-Wen;Tsai;Yi-Lin;Wu;Yen-Wen;Li;Hung-Yuan;Chang;Hsin-Yun;Wu;Chih-Hsing;Yang;Chih-Yu;Tarng;Der-Cherng;Huang;Chin-Chou;Ho;Li-Ting;Lin;Chao-Feng;Chien;Shih-Chieh;Wu;Yih-Jer;Yeh;Hung-I;Pan;Wen-Harn;Li;Yi-Heng
國立成功大學 2022-08 2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke Chen;Po-Sheng;Lee;Meng;Tang;Sung-Chun;Huang;Po-Hsun;Yeh;Hung-;I;Hou;Charles, Jia-Yin;Hsieh;I-Chang;Lee;Jiunn-Tay;Jeng;Jiann-Shing;Li;Yi-Heng
國立成功大學 2022-06-22 Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling Chen;Po-Sheng;Feng;Wen-Han;Tsai;Tzu-Hsien;Hong;Yi-Kai;Lee;An-Sheng;Chang;Kuan-Cheng;Chung;Hsing-Chun;Liu;Yen-Wen;Hsieh;Chih-Cheng;Fang;Yi-Hsian;Yang;Pei-Jung;Luo;Chawn-Yau;Liu;Ping-Yen;Cheng;Tsung-Lin;Li;Yi-Heng
國立成功大學 2022-02-24 Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy Huang;Sheng-Wei;Chen;Po-Wei;Feng;Wen-Han;Hsieh;I-Chang;Ho;Ming-Yun;Cheng;Chung-Wei;Yeh;Hung-;I;Chen;Ching-Pei;Huang;Wei-Chun;Fang;Ching-Chang;Lin;Hui-Wen;Lin;Sheng-Hsiang;Tsai;Chin-Feng;Su;Chun-Hung;Li;Yi-Heng
國立成功大學 2022-02 Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia Chang;Wei-Ting;Chen;Po-Wei;Lin;Hui-Wen;Kuo;Yu-Hsuan;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2022 Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study Lin;Jia-Ling;Chen;Po-Sheng;Lin;-Wen, Hui;Tsai;Liang-Miin;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2021-11 Endovascular Therapy for Venous Thromboembolic Diseases Su;Yi-Jia;Chang;Hsien-Yuan;Li;Yi-Heng
國立成功大學 2021-09-24 Genetic risk model for in-stent restenosis of second- and third-generation drug-eluting stents Liu;Yen-Wen;Huang;Mu-Shiang;Hsu;Ling-Wei;Chang;Hsien-Yuan;Lee;Cheng-Han;Lee;Chi-Ying;Chen;Dao-Peng;Li;Yi-Heng;Chao;Ting-Hsin;Su;Pei-Fang;Shen;Meng-Ru;Liu;Ping-Yen
國立成功大學 2021-07 Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies Chen;Po-Wei;Tsai;Zong-Yun;Chao;Ting-Hsing;Li;Yi-Heng;Hou;Charles, Jia-Yin;Liu;Ping-Yen
國立成功大學 2021-05-12 Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy Ho;Ming-Yun;Chen;Po-Wei;Feng;Wen-Han;Su;Chun-Hung;Huang;Sheng-Wei;Cheng;Chung-Wei;Yeh;Hung-I;Chen;Ching-Pei;Huang;Wei-Chun;Fang;Ching-Chang;Lin;Hui-Wen;Lin;Sheng-Hsiang;Hsieh;I-Chang;Li;Yi-Heng
國立成功大學 2021-03 Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel Lee;Cheng-Han;Lin;Hui-Wen;Lee;Nan-Yao;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2021-03 Reduced-Dose Prasugrel versus Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention A Meta-Analysis of Randomized and Observational Studies Lee;Cheng-Han;Huang;Mu-Shiang;Chao;Ting-Hsing;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2021-01 P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: Is It Safe to Abandon Aspirin? Feng;Wen-Han;Hsieh;I-Chang;Li;Yi-Heng
國立成功大學 2020-12 Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus Chen;Ju-Yi;Lee;Shuenn-Yuh;Li;Yi-Heng;Lin;Chia-Yu;Shieh;Meng-Dar;Ciou;Ding-Siang
國立成功大學 2020-10 Calcified abdominal cocoons Chen;Ju-Yi;Li;Yi-Heng
國立成功大學 2020-09 Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guidelines or Consensus Around the World Lin;Jia-Ling;Huang;Po-Hsun;Yeh;Hung-;I;Li;Yi-Heng
國立成功大學 2020-06 P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Chen;Po-Wei;Feng;Wen-Han;Ho;Ming-Yun;Su;Chun-Hung;Huang;Sheng-Wei;Cheng;Chung-Wei;Yeh;Hung-;I;Chen;Ching-Pei;Huang;Wei-Chun;Fang;Ching-Chang;Lin;Hui-Wen;Lin;Sheng-Hsiang;Hsieh;I-Chang;Li;Yi-Heng
國立成功大學 2020-06 Ef ficacy and Safety of High -intensity Statins in Patients With Acute Myocardial Infarction: An Asian Perspective Chen;Po-Sheng;Lin;Sheng-Hsiang;Lee;Cheng-Han;Lin;Hui-Wen;Li;Yi-Heng
國立成功大學 2020-02 Changing Treatment Patterns in Patients With Venous Thromboembolism in Taiwan Lee;Cheng-Han;Fang;Ching-Chang;Tsai;Liang-Miin;Lin;Hui-Wen;Chen;Po-Sheng;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2019-10 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance Chien;Shih-Chieh;Chen;Po-Sheng;Huang;Yi-Hsiang;Tang;Sung-Chun;Li;Yi-Heng;Yeh;Hung-;I
國立成功大學 2019-08 The role of vascular smooth muscle cell membrane-bound thrombomodulin in neointima formation Wang;Kuan-Chieh;Chen;Po-Sheng;Chao;Ting-Hsing;Luo;Chawn-Yau;Chung;Hsing-Chun;Tseng;Shih-Ya;Huang;Ting-Yu;Lin;Ying-Li;Shi;Guey-Yueh;Wu;Hua-Lin;Li;Yi-Heng
國立成功大學 2019-06 The role of N-terminal pro-B-type natriuretic peptide in prognostic evaluation of heart failure Lam;Carolyn, S. P.;Li;Yi-Heng;Bayes-Genis;Antoni;Ariyachaipanich;Aekarach;Huan, Do Quang;Sato;Naoki;Kahale;Pravin;Cuong, Ta Manh;Dong;Yugang;Li;Xinli;Zhou;Yanli
國立成功大學 2019-03 Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan Fang;Chen-Wen;Tsai;Yi-Te;Chou;Ping-Chen;Chen;Hsi-Ming;Lu;Chien-Ming;Tsao;Chen-Rong;Chen;Chih-Lin;Sun;Mu-Chien;Shih;Yu-Song;Hsieh;Cheng-Yang;Chen;Lu-An;Chen;Po-Lin;Yeh;Jung-Tze;Li;Yi-Heng
國立成功大學 2018-12-15 Patterns of Acute Myocardial Infarction in Taiwan from 2009 to 2015 Lee;Cheng-Han;Fang;Ching-Chang;Tsai;Liang-Miin;Gan;Shu-Ting;Lin;Sheng-Hsiang;Li;Yi-Heng
國立成功大學 2018-10 Comparison of the 2017 Taiwan lipid guidelines and the Western lipid guidelines for high risk patients Li;Yi-Heng;Yeh;Hung-I;Jeng;Jiann-Shing;Charng;Min-Ji
國立成功大學 2018-09 Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients Li;Yi-Heng;Chao;Ting-Hsing;Liu;-Yen, Ping;Ueng;Kwo-Chang;Yeh;Hung-I
國立成功大學 2018-03-20 The Taiwan Heart Registries Its Influence on Cardiovascular Patient Care Wu;Cho-Kai;Juang;Jimmy, Jyh-Ming;Chiang;Jiun-Yang;Li;Yi-Heng;Tsai;Chia-Ti;Chiang;Fu-Tien
國立成功大學 2018-03 Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan Lee;Cheng-Han;Cheng;Ching-Lan;Yang;Kao, Yea-Huei;Chao;Ting-Hsing;Chen;Ju-Yi;Li;Yi-Heng
國立成功大學 2018-02 Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan Tsai;Li-Kai;Lin;Huey-Juan;Chua;Su-Kiat;Liao;Pen-Chih;Yang;Yuan-Po;Chou;Ping-Chen;Lee;Chun-Wei;Lin;Mao-Jen;Chen;Hsi-Ming;Yeh;Jung-Tze;Li;Yi-Heng
國立成功大學 2017-09 Recovery of gold from industrial wastewater by extracellular proteins obtained from a thermophilic bacterium Tepidimonas fonticaldi AT-A2 Han;Yin-Lung;Wu;Jen-Hao;Cheng;Chieh-Lun;Nagarajan;Dillirani;Lee;Ching-Ray;Li;Yi-Heng;Lo;Yung-Chung;Chang;Jo-Shu
國立成功大學 2017-06-12 Recombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice Chen;Po-Sheng;Wang;Kuan-Chieh;Chao;Ting-Hsing;Chung;Hsing-Chun;Tseng;Shi-Ya;Luo;Chawn-Yau;Shi;Guey-Yueh;Wu;Hua-Lin;Li;Yi-Heng
國立成功大學 2017-05 Life cycle assessment of palm-derived biodiesel in Taiwan Maharjan;Sumit;Wang;Wei-Cheng;Teah;Yi, Heng
國立成功大學 2017-03 Ticagrelor safety profile in real-life setting of acute coronary syndrome patients Reply Chen;I-Chih;Lee;Cheng-Han;Li;Yi-Heng;Chao;Ting-Hsing
國立成功大學 2017-01-15 Calcium ion adsorption with extracellular proteins of thermophilic bacteria isolated from geothermal sites-A feasibility study Han;Ying-Lung;Lo;Yung-Chung;Cheng;Chieh-Lun;Yu;Wan-Ju;Nagarajan;Dillirani;Liu;Chih-Hsi;Li;Yi-Heng;Chang;Jo-Shu

Showing items 1-50 of 50  (1 Page(s) Totally)
1 
View [10|25|50] records per page